Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTrustpilot reviews for Wegovy-related services are everywhere, but they rarely answer the question most people are actually asking: is this medicine safe, does it work, and can I trust the pharmacy dispensing it? Wegovy (semaglutide) is a prescription-only weight-loss injection backed by large clinical trials, and any legitimate UK provider is regulated by the GPhC. Stars on a review platform tell you something about service experience; they tell you much less about clinical safety or whether a supply chain is genuine. Here is what the evidence actually says, and how to read provider ratings with a clear head.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
They don't. That is the short answer, and it matters. Trustpilot reviews typically capture whether a parcel arrived on time, whether customer service picked up the phone, and whether the reviewer felt their expectations were met. Those things are worth knowing about a provider. They say nothing reliable about whether semaglutide produced lasting weight loss for that person, whether their dosing was clinically appropriate, or whether the medicine they received was genuine and from a licensed UK supplier.
The actual evidence base for Wegovy comes from phase 3 trials. The STEP 1 trial, published in the New England Journal of Medicine, randomised nearly 2,000 adults and followed them for 68 weeks: participants on 2.4 mg semaglutide lost an average of around 15% of their body weight alongside lifestyle changes. That is a controlled, peer-reviewed finding. A cluster of five-star reviews on a retail platform is not an equivalent data source. The two can comfortably coexist, but only one of them should inform your clinical expectations.
A question our prescribers hear most weeks is some version of: "I saw great reviews for this provider online, does that mean I'm fine to order?" The answer is: reviews are a starting point for service due diligence, not a substitute for verifying that the pharmacy is GPhC-registered and that a qualified prescriber will assess your case.
Used carefully, review platforms do offer useful signal. Look for consistency in what reviewers describe about the clinical process: did the provider ask medical questions? Was there an identity check? Did someone review their answers before anything was dispatched? Positive reviews that mention a real clinical assessment, a pharmacist or prescriber making contact, and a structured titration plan are the ones that suggest a legitimately run service.
Conversely, reviews that praise how quickly or easily medicine arrived, how few questions were asked, or how cheap the whole thing was deserve scrutiny. Wegovy is a prescription-only medicine. Speed without clinical oversight is not a selling point, it is a warning sign. The MHRA has warned publicly about fake weight-loss pens sold online and via social media, with counterfeit pens found to contain insulin in some cases. Verifying a pharmacy on the GPhC register takes about 90 seconds and is a firmer check than any star rating.
Volume of reviews can also be misleading. A pharmacy that has been operating for years in a regulated way may have fewer reviews than a newer, more aggressively marketed service. Review count correlates with marketing spend, not with clinical quality or supply-chain integrity.
Many Wegovy-related Trustpilot pages are tied to pricing, and reviews that celebrate unusually low prices are worth treating with particular care. Eli Lilly's September 2025 list price increase for tirzepatide pushed private market rates significantly upward, and Novo Nordisk's semaglutide pricing has followed a similar trajectory. If a review from the past year describes pricing that seems well below the market range you would find on a legitimate treatment page, that is worth noting.
For context on what private Wegovy treatment costs and what that price should include (consultation, prescription, clinical review, and delivery), the Wegovy cost page covers the current landscape factually. A transparent provider will list exactly what is included in the price. One that does not is harder to evaluate, whatever their Trustpilot score says. If you want to read about how patients describe their experience of the medicine itself rather than just the service, our guide to Wegovy reviews on Trustpilot explains what that feedback typically reflects and where its limits lie.
NHS access to Wegovy exists under NICE guidance (TA875), but only via specialist weight management services, and waiting lists are commonly long. If you are exploring private options because the NHS route is not available to you right now, that is a practical decision many people are making. What matters is that the private route you choose is regulated, prescriber-led, and uses a licensed UK supply chain. The Wegovy treatment overview explains how the medicine is prescribed and what the clinical process involves, which is a more useful comparison tool than review scores alone.
Rather than treating Trustpilot as the primary filter, run this sequence. First, look up the pharmacy's GPhC premises registration number and confirm it on the register, legitimate services will display it openly. Second, check that the consultation process involves a qualified prescriber reviewing your answers, not an automated system. Third, confirm that identity and weight verification happen before any medicine is dispatched. Fourth, look for clarity about what the price includes: prescription fees, delivery, and aftercare should not be surprises on a separate invoice.
At nume, every consultation is read by a GPhC-registered Independent Prescriber on the same day it is submitted. Photo ID and live weight checks are part of the standard process, not optional extras. Our GPhC premises registration is 9012878, verifiable at the GPhC pharmacy register. That kind of transparency is what a review score cannot convey, and is what actually keeps you safe with a prescription-only medicine.
Wegovy also has a side-effect profile worth understanding before starting. GI symptoms are the most common, and if you are wondering whether bloating and wind are part of that picture, our page on whether Wegovy makes you fart a lot gives an honest clinical explanation of why that happens and how to manage it. There are also important notes around contraception and surgical procedures, and there are eligibility considerations that apply to certain professions, including a detailed look at whether pilots can take Wegovy given aviation medical requirements. The semaglutide information page covers the clinical picture in full. If you have specific concerns, our team is available seven days a week.
If you have read the evidence, checked provider credentials, and are ready to explore whether Wegovy is clinically suitable for you, start your free consultation and a prescriber will review your case the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.